Economics ❯ Market Trends

Pharmaceutical Market

Drug Pricing Investment Strategies Drug Sales Investment Opportunities Investment Consumer Behavior Stock Performance Biopharmaceutical Growth Price Increases Generics

GSK to Acquire 35Pharma for $950 Million to Add Pulmonary Hypertension Candidate HS235

The signed deal would place an activin‑pathway therapy with phase 1 data into GSK’s RI&I pipeline pending U.S. and Canadian clearance.

Novo Nordisk Slumps on Weak 2026 Outlook as GLP-1 Pill Uptake Builds

Pfizer Tops Q4 Estimates but Posts Loss on $4.4 Billion Charge, Reaffirms 2026 Outlook

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

BioNTech Raises 2025 Sales Outlook After $1.5 Billion BMS Payment

dm Targets 2025 Launch of Czech-Based Online Pharmacy for OTC Drugs in Germany

South Korea Launches K-Bio Leap Strategy to Speed Drug Approvals and Double Exports by 2030

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets

Mexican Pharma Industry Rejects Trump’s 200% Tariff Threat as Exports Surge

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

Merck in Advanced Talks to Acquire Springworks Therapeutics for $3.5 Billion

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

Merck to Acquire EyeBio for Up to $3 Billion